LAMP1 and neoplasm: We found that 88.8% of CD107A+ TCRB clones in PBLs were presented in TCRB repertoire of tumor tissue (Supplementary Fig. 6d), suggesting that most of activated T cells (CD107A+) in PBLs also existed in tumors and could have similar anti-tumor function to T cells in tumor tissue.